Scopus
🔓 Açık Erişim YÖKSİS DOI Eşleşti
SJR Q1
The Retrograde Approach to Chronic Total Occlusion Percutaneous Coronary Interventions: Technical Analysis and Procedural Outcomes
Jacc Cardiovascular Interventions · Kasım 2023
Özet
Background: Retrograde chronic total occlusion (CTO) percutaneous coronary intervention (PCI) is associated with lower success and higher complication rates when compared with the antegrade approach. Objectives: This study sought to assess contemporary techniques and outcomes of retrograde CTO PCI. Methods: We examined the baseline characteristics, procedural techniques and outcomes of 4,058 retrograde CTO PCIs performed at 44 centers between 2012 and 2023. Major adverse cardiac events (MACE) included any of the following in-hospital events: death, myocardial infarction, repeat target vessel revascularization, pericardiocentesis, cardiac surgery, and stroke. Results: The average J-CTO (Multicenter CTO Registry in Japan) score was 3.1 ± 1.1. Retrograde crossing was successful in 60.5% and lesion crossing in 81.6% of cases. The collaterals pathways successfully used were septals in 62.0%, saphenous vein grafts in 17.4%, and epicardials in 19.1%. The technical and procedural success rates were 78.7% and 76.6%, respectively. When retrograde crossing failed, technical success was achieved in 50.3% of cases using the antegrade approach. In-hospital MACE was 3.5%. The clinical coronary perforation rate was 5.8%. The incidence of in-hospital MACE with retrograde true lumen crossing, just marker antegrade crossing, conventional reverse controlled antegrade and retrograde tracking (CART), contemporary reverse CART, extended reverse CART, guide-extension reverse CART, and CART was 2.1%, 0.8%, 5.5%, 3.0%, 2.1%, 3.2%, and 4.1%, respectively; P = 0.01). Conclusions: Retrograde CTO PCI is utilized in highly complex cases and yields moderate success rates with 5.8% perforation and 3.5% periprocedural MACE rates. Among retrograde crossing strategies, retrograde true lumen puncture was the safest. There is need for improvement of the efficacy and safety of retrograde CTO PCI.
YÖKSİS Kayıtları
The Retrograde Approach to Chronic Total Occlusion Percutaneous Coronary Interventions
JACC: Cardiovascular Interventions · 2023 SCI-Expanded
Prof. Dr. NAZİF AYGÜL →
YÖKSİS Kayıtları — ISSN Eşleşmesi
Bu dergide (ISSN eşleşmesi) kurumun 2 kaydı bulundu.
YÖKSİS Kayıtları — ISSN Eşleşmesi
Bu dergide (ISSN eşleşmesi) kurumun 2 kaydı bulundu.
The Retrograde Approach to Chronic Total Occlusion Percutaneous Coronary Interventions
2023 ISSN: 1936-8798 SCI-Expanded Q1
Prof. Dr. NAZİF AYGÜL →
Predicting Successful Chronic Total Occlusion Crossing With Primary Antegrade Wiring Using Machine Learning
2024 ISSN: 1936-8798 SCI-Expanded Q1
Prof. Dr. NAZİF AYGÜL →
Makale Bilgileri
Toplam Atıf
38 atıf
· Scopus
ISSN19368798
Yayın TarihiKasım 2023
Cilt / Sayfa16 · 2748-2762
Scopus ID2-s2.0-85176401337
Erişim🔓 Açık Erişim
Kurumlar
Acibadem Kocaeli Hospital
Izmir Turkey
Centennial Medical Center
Nashville United States
Cleveland Clinic Foundation
Cleveland United States
Emory Healthcare
Atlanta United States
E.N. Meshalkin National Medical Research Center
Novosibirsk Russian Federation
Henry Ford Cardiovascular Division
Detroit United States
Massachusetts General Hospital
Boston United States
Minneapolis Heart Institute
Minneapolis United States
Morristown Medical Center
Nen Jersey United States
Oklahoma Heart Institute
Tulsa United States
Presbyterian Hospital of Dallas
Dallas United States
Selçuk Üniversitesi
Selçuklu Turkey
The Christ Hospital - Cincinnati
Cincinnati United States
University Hospitals Case Medical Center
Cleveland United States
University of Washington School of Medicine
Seattle United States
York Hospital, Pennsylvania
York United States
Havuzumuzdaki Atıflar 0
Bu makaleye, sistemimizdeki Scopus veritabanında bulunan 0 makale atıf yapmıştır. Scopus genel atıf sayısı: 38.
Bu makaleye, kendi Scopus havuzumuzdaki başka bir makaleden atıf kaydı bulunmuyor.
Scimago Dergi (ISSN Eşleşmesi)
JACC: Cardiovascular Interventions
Q1
SJR Skoru3,588
H-Index174
YayıncıElsevier Inc.
ÜlkeUnited States
Cardiology and Cardiovascular Medicine (Q1)
Medicine (miscellaneous) (Q1)
Metrikler
38
Atıf